SFCM
KRYS icon

Seven Fleet Capital Management’s Krystal Biotech KRYS Stock Holding History

Seven Fleet Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$659K Sell
1,774
-2,542
-59% -$760K 0.11% 70
2026
Q1 		$1.11M Buy
4,316
+316
+8% +$84.1K 0.35% 56
2025
Q4 		$986K Buy
+4,000
New +$842K 0.67% 28

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Seven Fleet Capital Management's KRYS Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Krystal Biotech (KRYS) stake by 59% in Q2 2026, selling an estimated $760K and leaving 1,774 shares worth $659K. The position accounts for 0.11% of the portfolio, ranked #70.

Seven Fleet Capital Management first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.11M in Q1 2026. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Seven Fleet Capital Management held 1,774 shares of Krystal Biotech worth $659K as of Q2 2026.
  • Seven Fleet Capital Management sold 2,542 Krystal Biotech shares in Q2 2026, an estimated $760K.
  • Krystal Biotech made up 0.11% of Seven Fleet Capital Management's portfolio in Q2 2026, its #70 holding.
  • Seven Fleet Capital Management first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Krystal Biotech position peaked at $1.11M in Q1 2026.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.